Who owns the TEVA trademark?

The TEVA trademark is owned by Teva Pharmaceutical Industries Limited.

What class is the TEVA trademark registered in?

The TEVA trademark is registered in Class 036 (Insurance, financial & real estate services).

What is the serial number for TEVA?

The USPTO serial number for TEVA is 88663880.

What is the registration number for TEVA?

TEVA is registered under USPTO registration number 6159940.

Sealvo

Home Search: TEVATEVA #88663880

Back

Updated Sep 27, 2026·10 searches this week

View on USPTO TSDR Find similar marks

TEV

USPTO Trademark Record

REGISTERED

TEVA

SN 88663880·Reg 6159940·Filed Oct 22, 2019

Owner Teva Pharmaceutical Industries Limited

Financial, monetary and banking services; insurance services; real estate services.

TEVA (Serial No. 88663880), Registration No. 6159940, is a registered US trademark filed on Oct 22, 2019 by Teva Pharmaceutical Industries Limited. This trademark covers Class 036 (Insurance, financial & real estate services).

renewal grace 6y period: March 22, 2027175 days remaining

Conflict Analysis

Full conflict analysis for TEVA (SN 88663880) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

TEVA (Reg. #6159940) is a registered US trademark that has been protecting its owner, Teva Pharmaceutical Industries Limited, since 2019. The mark covers Class 036 (Insurance, financial & real estate services). Goods and services include Financial, monetary and banking services; insurance services; real estate services.. The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 22, 2019

SERIAL

88663880

REG#

6159940

REGISTERED

Sep 22, 2020

Filing Information

StatusREGISTERED

Filing DateOct 22, 2019

Serial Number88663880

Registration No.6159940

Registration DateSep 22, 2020

Status DateSep 22, 2020

Published for OppositionMar 17, 2020

Filing Basis & Declarations

Use Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 036Insurance, financial & real estate services

US codes: 100, 101, 102

First use anywhere: Feb 28, 2018

First use in commerce: Feb 28, 2018

Financial, monetary and banking services; insurance services; real estate services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

34 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 04, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 04, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 04, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 04, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Feb 04, 2026

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 04, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 22, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Oct 22, 2021

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 22, 2021

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 22, 2021

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 22, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Oct 22, 2021

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

REGISTERED-PRINCIPAL REGISTER

Sep 22, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 20, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 19, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 05, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Aug 05, 2020

STATEMENT OF USE PROCESSING COMPLETE

ASSIGNED TO EXAMINER

Jul 27, 2020

ASSIGNED TO EXAMINER

USE AMENDMENT FILED

Jul 22, 2020

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Jul 22, 2020

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 12, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 17, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 17, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 26, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Feb 07, 2020

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 29, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT E-MAILED

Jan 29, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 29, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 29, 2020

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Jan 29, 2020

EXAMINERS AMENDMENT -WRITTEN

ASSIGNED TO EXAMINER

Jan 23, 2020

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 29, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 28, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 25, 2019

NEW APPLICATION ENTERED

Other Marks by Teva Pharmaceutical Industries Limited

Additional USPTO filings from the same owner.

TEV

TEVA

86916574

Teva Pharmaceutical Industries Limited

REGISTERED

INT

INTEVAGENCE THE EXPERT FORUM FOR ADVANCING ONCOLOGY CARE

85908944

TEVA Pharmaceutical Industries Limited

REGISTERED

COP

COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY

87646713

Teva Pharmaceutical Industries Limited

REGISTERED

COP

COPAXONE ITRACKER

85779326

TEVA Pharmaceutical Industries Limited

REGISTERED

Other Marks in Class 036 — Insurance, financial & real estate services

Recently filed and registered marks in the same international class.

TEV

TEVA

86916141

Teva Pharmaceutical Industries Limited

REGISTERED

TEV

TEVA

86916563

Teva Pharmaceutical Industries Limited

ABANDONED

TEV

TEVA PROPERTIES

99071924

TEVA PROPERTIES, LLC

REGISTERED

TEV

TEVA TOTAL SUPPORT

99451265

Teva Pharmaceuticals USA, Inc.

PENDING

Other Marks by Lori Wolfe

Additional USPTO filings handled by the same attorney of record.

MYL

MY LITTLE SUDOCREM

79430940

REGISTERED

LOG

LogoMark

73561348

REGISTERED

SIM

SIMLANDI

99425494

REGISTERED

SEL

SELARSDI

97477128

REGISTERED

TEVA

Run a conflict check

Other Marks by Teva Pharmaceutical Industries Limited

Other Marks in Class 036 — Insurance, financial & real estate services

Other Marks by Lori Wolfe

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company